Intercept Pharmaceuticals reported $559.4M in Assets for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Acadia Pharmaceuticals ACAD:US USD 602.49M 10.28M
Acorda Therapeutics ACOR:US USD 393.34M 12.97M
Alnylam Pharmaceuticals ALNY:US USD 3.54B 204.84M
Amarin AMRN:US USD 908.3M 64.93M
Amgen AMGN:US USD 65.12B 1.42B
Arrowhead Research ARWR:US USD 691.94M 59.84M
AstraZeneca AZN:LN USD 94.18B 2.39B
Biogen BIIB:US USD 24.85B 227.2M
Bluebird Bio BLUE:US USD 520.1M 53.49M
Enanta Pharmaceuticals ENTA:US USD 375.41M 9.8M
Esperion Therapeutics ESPR:US USD 312.83M 8.85M
Galectin Therapeutics GALT:US USD 17.91M 7.97M
Gilead Sciences GILD:US USD 63.17B 614M
GlaxoSmithKline GSK:LN GBP 60.15B 167M
Intercept Pharmaceuticals ICPT:US USD 559.4M 60.81M
IONIS PHARMACEUT IONS:US USD 2.42B 34.16M
Moderna Inc MRNA:US USD 26.06B 13M
Neurocrine Biosciences NBIX:US USD 2.14B 137.7M
Novartis NOVN:VX USD 118.46B 4.45B
Ptc Therapeutics PTCT:US USD 1.58B 227.66M
Regeneron Pharmaceuticals REGN:US USD 27.68B 472M
Sangamo Biosciences SGMO:US USD 593.91M 23.21M
Sarepta Therapeutics SRPT:US USD 3.16B 159.3M
Vertex Pharmaceuticals VRTX:US USD 16.71B 1.12B
YTE INCY:US USD 5.51B 191.18M